| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f1bedf26ed145fcc46cdd7f7c6b76653 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate |
2018-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07db24f558c873d99bea1c512c57ba1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3385eba680bda762ce1c9bfbadb06e1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_007dfbb7c043f7e844a71d5da84c8d38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4eb1e8d4f38c66c0dbe11a2efb9a6843 |
| publicationDate |
2019-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019129100-A1 |
| titleOfInvention |
Crystal form of valbenazine di-p-toluenesulfonate, preparation method thereof and use thereof |
| abstract |
A crystal form of Valbenazine di-p-toluenesulfonate, a preparation method therefor, a pharmaceutical composition comprising the crystal form, and a use of the crystal form in the preparation of a vesicular monoamine transporter 2 inhibitor and a pharmaceutical preparation for treating tardive dyskinesia. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10689380-B1 |
| priorityDate |
2017-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |